Pharmiweb ChannelsAll | PharmaCo | Clinical Research | R&D/BioTech | Sales/Mktg | Healthcare | Recruitment | Pharmacy | Medical Comms

Pharmiweb.com RSS Feed Pharmiweb.com RSS Feeds

Pharmiweb.com RSS Feed PharmiWeb Candidate Blog

Pharmiweb.com RSS Feed PharmiWeb Client Blog

Advertising

Press Release

Heliospectra Exhibiting at Marijuana Business Conference and Expo in Las Vegas

Heliospectra
Posted on: 16 Nov 16

Heliospectra AB (publ) (STO:HELIO), a world leader in intelligent lighting technology for controlled environment horticulture, today announced its exhibition at the Marijuana Business Conference and Expo, November 16-18, 2016 in Las Vegas, Nevada. Heliospectra will showcase integrated LED light systems in booth #235, meeting with more than 9,500 medicinal cannabis cultivators, licensed facility owners and industry leaders during the fifth annual MJBizCon event hosted by the editors of Marijuana Business Daily.

With the influx of licensed facilities, increase in municipal and state regulations, and downward market pricing pressure, many cultivators and business operations teams attending this year’s conference are seeking new technology solutions to improve profitability by lowering cost of goods sold and boosting revenue.

“Since cannabis is a light hungry plant, cultivators replace traditional HID lamps with LED systems to reduce energy and HVAC costs for rapid ROI,” said Caroline Nordahl Wells, General Manager, Americas for Heliospectra. "But cannabis growers and CFOs quickly discover even more exciting benefits only achievable with the Heliospectra LED solution, including the ability to reduce turn times for an additional annual harvest and consistently hit yield and potency targets. Additionally, cultivators are rapidly developing custom-crafted products through simple intensity and wavelength adjustments.”

Heliospectra combines several different groups of versatile light emitting diodes (LEDs) with optics, remote sensing techniques, and a robust heat dissipation solution, which is critical for maintaining temperature and relative humidity in large-scale, commercial cannabis grow operations. The Company’s IoT-enabled light strategies and smart controls also pair with a multitude of sensor technologies to deliver business critical data back to growers.

Heliospectra continues strong sales momentum of its programmable, full-spectrum LED lighting solutions within North American medicinal cannabis communities, bolstered by the unprecedented customer results achieved at The Grove Nevada, Green Leaf in Alaska and other cultivation leaders who maximize revenue and ROI with consistent harvests and quality crops.

Join the Heliospectra Conversation

* Read more at www.heliospectra.com/blog

* Follow @Heliospectra on Twitter

* Join the #JustSayNoToHPS community at www.instagram.com/justsaynotohps/

About Heliospectra AB

Heliospectra AB (publ) (OTCQB: HLSPY, FIRSTNORTH: HELIO) (www.heliospectra.com) specializes in intelligent lighting technology for plant research and greenhouse cultivation. The Company's lighting system provides an effective and durable technology for cultivating greenhouse and indoor plants by combining several different groups of versatile light emitting diodes (LEDs) with optics, remote sensing techniques, and a robust heat dissipation solution. This proprietary setup gives growers the ability to control the intensity and wavelengths of the light emitted, creating a spectrum specifically adjusted to different plant species and growth stages to better facilitate photosynthesis. The complete, highly engineered lamp produces crops that look better, taste better, and have a longer shelf-life than those grown under HID lamps. The technology not only reduces energy consumption by up to 50%, but also helps stimulate growth characteristics and improve plant quality. Other benefits include reduced light pollution, lower mercury use due to the avoidance of traditional HID/HPS bulbs, and less HVAC investment and monthly expense requirements.

Heliospectra products are based on in-depth knowledge in plant physiology and photosynthesis along with a unique way to utilize modern LED technology. After six years of development in Sweden, the company is expanding into the international market. The Company has raised more than $21 million in capital and received more than $2.6 million through academic scholarships and grants. It has also received numerous awards for forward-thinking technology. Biggest shareholders: Weland Steel www.welandstal.se, Swedish Industrial Fund www.industrifonden.se, Midroc www.midroc.se, Avanza Pension www.avanza.se.

Forward-Looking Statements

The statements in this press release constitute forward-looking statements within the meaning of federal securities laws. Such statements are based on our current beliefs and expectations and are inherently subject to significant business, economic and competitive uncertainties and contingencies, many of which are beyond our control. In addition, such forward-looking statements are subject to assumptions with respect to future business strategies and decisions that are subject to change. Potential risks and uncertainties include, but are not limited to, technical advances in the industry as well as political and economic conditions present within the industry. We do not take any obligation to update any forward-looking statement to reflect events or developments after a forward-looking statement was made.

This information is information that Heliospectra AB (publ) is obliged to make public pursuant to the EU Market Abuse Regulation. The information was submitted for publication, through the agency of the contact person set out above, at 15:00 CET / 8 AM CT on November 16, 2016.

G&W is Heliospectra's Certified Advisor for Nasdaq First North - www.gwkapital.sewww.heliospectra.com

This information was brought to you by Cision http://news.cision.com

View source version on businesswire.com: http://www.businesswire.com/news/home/20161116005933/en/

Business Wire
www.businesswire.com

Last updated on: 16/11/2016

Advertising
Share | | |
Site Map | Privacy & Security | Cookies | Terms and Conditions

PharmiWeb.com is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on PharmiWeb.com is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.